“Since 2021, the mRNA pipeline has tripled,” Lorenzo De Benedictis providing delegates at #BPIEU with some staggering facts about how the modality has grown since COVID-19.
Meanwhile Jim Xu from Bristol Myers Squibb talks upstream process dev "at pandemic speed" in the cell culture track here at #biotechweekboston ... it's good to be back!